Prospective clinical trial of 12-fraction carbon-ion radiotherapy for primary renal cell carcinoma

The aims of this study were to clarify the safety and efficacy of 12-fraction carbon-ion radiotherapy (CIRT) for primary renal cell carcinoma (RCC) and to confirm the recommended dose in a prospective clinical trial. This clinical trial was planned as a non-randomized, open-label, single-center phas...

Descripción completa

Detalles Bibliográficos
Autores principales: Kasuya, Goro, Tsuji, Hiroshi, Nomiya, Takuma, Makishima, Hirokazu, Haruyama, Yasuo, Kobashi, Gen, Hayashi, Kazuhiko, Ebner, Daniel K., Omatsu, Tokuhiko, Kishimoto, Riwa, Yasuda, Shigeo, Igarashi, Tatsuo, Oya, Mototsugu, Akakura, Koichiro, Suzuki, Hiroyoshi, Ichikawa, Tomohiko, Shimazaki, Jun, Kamada, Tadashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343760/
https://www.ncbi.nlm.nih.gov/pubmed/30713604
http://dx.doi.org/10.18632/oncotarget.26539

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343760/
https://www.ncbi.nlm.nih.gov/pubmed/30713604
http://dx.doi.org/10.18632/oncotarget.26539

Ejemplares similares